How are they Solving it?
The point-of-care diagnostics segment offers huge potential for microfluidics. But there is a need to bridge the gap between basic-science innovation and commercialization. MZP develops point-of-care diagnostic devices based on microfluidics, with a focus in usefulness, simplicity, robustness and scalability.
MZP have successfully applied this approach in a portable, low-cost, point-of-care viscoelastic coagulation analyzer, intended for the management of bleeding in critical care patients. Furthermore, they plan to apply the advantages of microfluidics, such as small volume requirements, portability, integration, multiplexed screening and flow based analysis in the development of a flow-based global hemostasis evaluation platform. Finally, their vision is to develop and integrate a portfolio of standardized microfluidic modules that will allow efficient and robust implementation of new POC diagnostic devices.